Tumors in Genetic Flux: Biomarker Discovery for Heterogeneous Pancreatic Metastases

One of the key factors contributing to the poor prognosis for pancreatic cancer is that, at initial presentation, almost 50% of patients already have distant metastases to other body organs. As a further complication, research has now shown that spread can occur from different subclones initiated within the primary tumor. Although biomarker discovery is enhancing Read the rest of this article

The post Tumors in Genetic Flux: Biomarker Discovery for Heterogeneous Pancreatic Metastases appeared first on Accelerating Science.

from http://ift.tt/1z3DrNO
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s